Finance

Lists
Why is 688799 down 3,65%?
Dive Deeper
688799:SHA
Hunan Warrant Pharmaceutical Co Ltd
CN¥47,98
-3,65%
(-1,82) 1D
13 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688799...
Open
CN¥48,95
High
CN¥48,95
Low
CN¥45,45
Mkt. cap
7,01 mjd
Avg. vol.
2,76 m
Volume
2,79 m
Dividend
0,37%
Quarterly dividend
CN¥0,04
Ex-dividend date
01 Jul. 2026
P/E ratio
27,22
52-wk high
CN¥65,20
52-wk low
CN¥40,33
EPS
CN¥1,76
No. of employees
1 k
Open
CN¥48,95
High
CN¥48,95
Low
CN¥45,45
Mkt. cap
7,01 mjd
Avg. vol.
2,76 m
Volume
2,79 m
Dividend
0,37%
Quarterly dividend
CN¥0,04
Ex-dividend date
01 Jul. 2026
P/E ratio
27,22
52-wk high
CN¥65,20
52-wk low
CN¥40,33
EPS
CN¥1,76
No. of employees
1 k
News stories
From web sources and news partners
About Hunan Warrant Pharmaceutical Co Ltd
CEO-
Employees1,33 k
Founded30 Apr. 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
372,11 m
418,41 m
324,55 m
336,15 m
Cost of goods sold
146,21 m
171,71 m
138,64 m
149,70 m
Cost of revenue
146,21 m
171,71 m
138,64 m
149,70 m
Research and development expenses
21,39 m
33,80 m
21,01 m
32,75 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151,42 m
176,85 m
128,44 m
113,95 m
Operating expense
162,18 m
217,76 m
148,00 m
148,57 m
Total operating expenses
308,40 m
389,47 m
286,64 m
298,26 m
Operating income
63,71 m
28,93 m
37,90 m
37,88 m
Other non operating income
-1,89 m
2,06 m
-667,11 k
-7,06 m
EBT including unusual items
140,61 m
25,06 m
33,19 m
41,39 m
EBT excluding unusual items
151,81 m
19,87 m
37,75 m
30,46 m
Income tax expense
5,78 m
-6,09 m
6,31 m
3,67 m
Effective tax rate
4,11%
-24,30%
19,02%
8,86%
Other operating expenses
-10,17 m
6,34 m
700,93 k
724,62 k
Net income
136,01 m
31,16 m
26,88 m
37,72 m
Net profit margin
36,55%
7,45%
8,28%
11,22%
Earnings per share
-
-
-
-
Interest and investment income
89,80 m
-
1,68 m
2,40 m
Interest expense
-
-10,14 m
-1,17 m
-1,36 m
Net interest expenses
89,80 m
-10,14 m
517,17 k
1,04 m
Depreciation and amortization charges
-
-
-
-
EBITDA
80,94 m
46,70 m
55,67 m
57,72 m
Gain or loss from assets sale
-
413,00
-
-
AI content may include mistakes. Learn more
Google-programme